Patents by Inventor Meagan Rouse

Meagan Rouse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHIBITORS OF Akt ACTIVITY
    Publication number: 20110196009
    Abstract: Invented are novel heterocyclic carboxamide compounds, the use of such compounds as inhibitors of protein kinase B activity and in the treatment of cancer and arthritis.
    Type: Application
    Filed: October 14, 2009
    Publication date: August 11, 2011
    Inventors: Meagan Rouse, Mark Andrew Seefeld
  • Antibacterial Agents
    Publication number: 20080234256
    Abstract: Naphthyridine and related derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.
    Type: Application
    Filed: January 24, 2006
    Publication date: September 25, 2008
    Applicant: Glaxo Group Limited
    Inventors: William Miller, Meagan Rouse, Mark Seefeld
  • Antibacterial Agents
    Publication number: 20070270417
    Abstract: Naphthalene, quinoline, quinoxaline and naphthyridine derivatives useful in the treatment bacterial infections in mammals, particularly humans, are disclosed herein.
    Type: Application
    Filed: July 21, 2005
    Publication date: November 22, 2007
    Applicant: GLAXO GROUP LIMITED
    Inventors: William Miller, Meagan Rouse, Mark Seefeld
  • Antibacterial Agents
    Publication number: 20070254872
    Abstract: Naphthalene, quinoline, quinoxaline and naphthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.
    Type: Application
    Filed: July 8, 2005
    Publication date: November 1, 2007
    Applicant: GLAXO GROUP LIMITED
    Inventors: William Miller, Meagan Rouse, Mark Seefeld
  • Antibacterial agents
    Publication number: 20070161627
    Abstract: Naphthalene, quinoline, quinoxaline and naphthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.
    Type: Application
    Filed: August 9, 2005
    Publication date: July 12, 2007
    Inventors: William Miller, Meagan Rouse, Mark Seefeld